Effects of chemotherapy (busulfan-hydroxyurea) and interferon-alfa on bone marrow morphologic features in chronic myelogenous leukemia: Histochemical and morphometric study on sequential trephine biopsy specimens with special emphasis on dynamic features

American Journal of Clinical Pathology

Volumn 114, Issue 1, 2000, Pages 57-65

  Thiele, Juergen ^a   Kvasnicka, Hans M ^a   Schmitt Graeff, Annette ^a   Bundschuh, Susanne ^a   Biermann, Teresa ^a   Roessler, Gernod ^a   Wasmus, Maria ^a   Diehl, Volker ^a   Zankovich, Rudolf ^a   Schaefer, Hans E ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Chronic myelogenous leukemia; CML; Erythrocytopoiesis; Macrophages; Megakaryocytes; Myelofibrosis; Therapy related changes

Indexed keywords

ALPHA INTERFERON; BUSULFAN; CD68 ANTIGEN; HYDROXYUREA; MONOCLONAL ANTIBODY; RETICULIN;

ADULT; ARTICLE; BONE MARROW; BONE MARROW BIOPSY; CHRONIC MYELOID LEUKEMIA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEGAKARYOPOIESIS; MYELOFIBROSIS; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; BIOPSY; BONE MARROW; BUSULFAN; DISEASE PROGRESSION; FEMALE; HISTOCYTOCHEMISTRY; HUMANS; HYDROXYUREA; INTERFERON-ALPHA; LEUKEMIA, MYELOID, CHRONIC; MALE; MEGAKARYOCYTES; MIDDLE AGED; MYELOFIBROSIS; RETROSPECTIVE STUDIES; TREPHINING;

EID: 18344395126     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/XMGX-7HQ8-7PLU-LQ9M     Document Type: Article

References (46)

1. Treatment of chronic myelogenous leukemia
2. Current aspects of drug therapy in Philadelphia-positive CML: Correlation of tumor burden with survival
3. Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia
4. Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-alpha therapy
5. Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia
6. An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: Developed for the American Society of Hematology
7. The impact of megakaryocyte proliferation for the evolution of myelofibrosis: Histological follow-up study in 186 patients with chronic myeloid leukemia
8. Clinicopathological impact of the interaction between megakaryocytes and myeloid stroma in chronic myeloproliferative disorders: A concise update
9. Reversal of myelofibrosis by hydroxyurea
10. Evolution of bone marrow fibrosis and stromal antigenic expression in chronic myeloid leukemia on alpha interferon and ara-c therapy
11. Effect of interferon-alpha therapy on bone marrow fibrosis in chronic myelogenous leukemia
12. The impact of interferon versus busulfan therapy on the reticulin stain-measured fibrosis in CML: A comparative morphometric study on sequential trephine biopsies
13. Histopathological changes in bone marrow biopsies from patients with chronic myeloid leukaemia after treatment with recombinant alpha-interferon
14. Pathogenesis of idiopathic myelofibrosis: Role of growth factors
15. TGF-beta and megakaryocytes in the pathogenesis of myelofibrosis in myeloproliferative disorders
16. Platelet derived growth factor expression, myelofibrosis and chronic myelogenous leukemia
17. How to fix, decalcify and stain paraffin embedded bone marrow biopsies
18. The immunohistological detection of platelets, megakaryocytes and thrombi in routinely processed specimens
19. 1) on trephine biopsies
20. Stimulated macrophages express a new glycoprotein receptor reactive with Griffonia simplicifolia I-B4 isolectin
21. Mononuclear phagocytes from human bone marrow progenitor cells: Morphology, surface phenotype, and functional properties of resting and activated cells
22. Acquired lipidosis of marrow macrophages: Birefringent blue crystals and Gaucher-like cells, sea-blue histiocytes, and grey-green crystals
23. Sea-blue histiocytes and Gaucher cells in bone marrow of patients with myeloid leukaemia
24. Frequency of pseudo-Gaucher cells in diagnostic bone marrow biopsies from patients with Ph-positive chronic myeloid leukaemia
25. An immunomorphometric study on megakaryocyte precursor cells in bone marrow tissue from patients with chronic myeloid leukemia (CML)
26. Erythropoiesis in CML: Immunohistomorphometric quantification, PCNA-reactivity, and influence on survival
27. Biology of the haemopoietic microenvironment
28. The cell biology of macrophage activation
29. The Philadelphia chromosome in human macrophages
30. Detection of the bcr/abl gene in bone marrow macrophages in CML and alterations during interferon therapy: A fluorescence in situ hybridization study on trephine biopsies
31. Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: Role of malignant stromal macrophages
32. Adhesive interactions of normal and leukemic human CD34+ myeloid progenitors: Role of marrow stromal, fibroblast, and cytomatrix components
33. Regulation of myeloid and lymphoid development of hematopoietic stem cells by bone marrow stromal cells
34. Integrin-mediated regulation of hematopoiesis: Do BCR/ABL-induced defects in integrin function underlie the abnormal circulation and proliferation of CML progenitors?
35. Potential mechanisms of action of interferon-alpha in CML
36. The effect of interferon-alpha on beta-1-integrin mediated adhesion and growth regulation in chronic myelogenous leukemia
37. Biotherapy of chronic myelogenous leukemia
38. Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7): A report of the French-American-British cooperative group
39. The production of transforming growth factor-beta in acute megakaryoblastic leukemia and its possible implications in myelofibrosis
40. Characterization of an acute micromegakaryocytic leukemia: Evidence for the pathogenesis of myelofibrosis
41. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix
42. A significant part of macrophage-derived growth factor consists of at least two forms of PDGF
43. Deposition of transforming growth factor-beta in the marrow in myelofibrosis, and the intracellular localization and secretion of TGF-beta by leukemic cells
44. A sequential histological study of bone marrow fibrosis in idiopathic myelofibrosis
45. Alpha interferon in the treatment of symptomatic myelofibrosis with myeloid metaplasia
46. Cytoreductive effect of recombinant alpha interferon in patients with myelofibrosis with myeloid metaplasia